Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank:DB01256_nanopub.RA4Yzkw4KFVLVutAsztFMTzNb7L6woNHaBjGUK9Jn7R_0#assertion>. }
Showing items 1 to 17 of
17
with 100 items per page.
- drugbank:DB01256 type drugbank_vocabulary:Drug assertion.
- drugbank:DB01256 label "Retapamulin [drugbank:DB01256]" assertion.
- drugbank:DB01256 seeAlso DB01256 assertion.
- drugbank:DB01256 seeAlso retapamulin-ointment.html assertion.
- drugbank:DB01256 seeAlso altabax.htm assertion.
- drugbank:DB01256 identifier "drugbank:DB01256" assertion.
- drugbank:DB01256 description "Retapamulin is a topical antibiotic developed by GlaxoSmithKline. It was approved by the United States Food and Drug Administration in April 2007 for the treatment of bacterial skin infections such as impetigo. It is marketed as an ointment under the name brand Altabax." assertion.
- drugbank:DB01256 title "Retapamulin" assertion.
- drugbank:DB01256 bio2rdf_vocabulary:identifier "DB01256" assertion.
- drugbank:DB01256 bio2rdf_vocabulary:namespace "drugbank" assertion.
- drugbank:DB01256 bio2rdf_vocabulary:uri "http://bio2rdf.org/drugbank:DB01256" assertion.
- drugbank:DB01256 bio2rdf_vocabulary:x-identifiers.org DB01256 assertion.
- drugbank:DB01256 drugbank_vocabulary:drugbank-id "DB01256" assertion.
- drugbank:DB01256 drugbank_vocabulary:x-cas cas:224452-66-8 assertion.
- drugbank:DB01256 drugbank_vocabulary:x-pharmgkb pharmgkb:PA164749341 assertion.
- drugbank:DB01256 drugbank_vocabulary:x-wikipedia wikipedia:Retapamulin assertion.
- drugbank:DB01256 drugbank_vocabulary:x-ndc ndc:0007-5180-05 assertion.